🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i....
Status
Active Not Recruiting
Location
UAB Childrens Hospital Harbor Center Neurology Dept
Start Date
2013-07-26
Trial ID
NCT01892722
Treatments Being Tested
In this study, researchers will learn more about the study drugs diroximel ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-11-16
Trial ID
NCT07483632
This study assessed the safety, tolerability and efficacy of two doses of o...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2006-06
Trial ID
NCT00355134
Treatments Being Tested
This study will evaluate the effect of treatment with fingolimod on the imm...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-08
Trial ID
NCT01199861
Treatments Being Tested
The purpose of this study is to evaluate whether FTY720 is effective in del...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2008-07-28
Trial ID
NCT00731692
This study evaluated disease control during different lengths of treatment ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2011-09
Trial ID
NCT01499667
Treatments Being Tested
The study was designed to evaluate the efficacy and safety of fingolimod in...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12-22
Trial ID
NCT01625182
Treatments Being Tested
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in p...
Status
Active Not Recruiting
Location
Arkansas Childrens Hosp Rsch Inst
Start Date
2021-10-05
Trial ID
NCT04926818
Treatments Being Tested
This double-blind, double-dummy study will evaluate the safety and efficacy...
Status
Active Not Recruiting
Location
UC San Diego
Start Date
2022-05-19
Trial ID
NCT05123703
Treatments Being Tested
To evaluate the safety and efficacy of fingolimod 0.5mg vs. placebo in MS p...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-06
Trial ID
NCT01941004
Treatments Being Tested